Effect of a 10-amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus

Oncogene

Volumn 12, Issue 10, 1996, Pages 2129-2135

  Li, Shui Nin ^a   Chang, Yu Sun ^b   Liu, Shih Tung ^b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

BNLF1; Epstein Barr virus; Latent membrane protein

Indexed keywords

CHIMERIC PROTEIN; MEMBRANE PROTEIN; MUTANT PROTEIN; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; EPSTEIN BARR VIRUS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRUCTURE ACTIVITY RELATION; VIRUS CELL TRANSFORMATION;

3T3 CELLS; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; DNA, VIRAL; GENE DELETION; GENES, VIRAL; HERPESVIRUS 4, HUMAN; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PLASMIDS; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; REPETITIVE SEQUENCES, NUCLEIC ACID; TRANSFECTION; VIRAL MATRIX PROTEINS;

ANIMALIA; HUMAN HERPESVIRUS 4;

EID: 0029950177     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Baichwal VR and Sudgen B. (1988). Oncogene, 2, 461-467.
2. Baichwal VR and Sudgen B. (1989). Oncogene, 4, 67-74.
3. Brousset P, Schlaifer D, Meggetto F, Bachmann E, Rothenberger S, Pris J, Delso G and Knecht H. (1994). Blood, 84, 2447-2451.
4. Chang Y-S, Shih L-Y, Peng C-L, Chen S-H and Liu S-T. (1990). Leukemia Res., 14, 309-320.
5. Chang Y-S, Su I-J, Chung P-J, Shu C-H, Ng C-K, Wu S-J and Liu S-T. (1995). Int. J. Cancer, 62, 673-677.
6. Chen M-L, Tsai C-N, Liang C-L, Shu C-H, Huang C-R, Sulitzeanu D, Liu S-T and Chang Y-S. (1992). Oncogene, 7, 2131-2140.
7. Chen M-L, Wu R-C, Liu S-T and Chang Y-S. (1995). Virus Res., 37, 75-84.
8. Cohen JI, Wang F, Mannick J and Kieff E. (1989). Proc. Natl. Acad. Sci. USA, 86, 9558-9562.
9. de Wet JR, Wood KV, DeLuca M, Helinski DR and Subramani S. (1987). Mol. Cell. Biol., 7, 725-737.
10. Epstein MA and Barr YM. (1964). Lancet, 1, 702-703.
11. Fahraeus R, Fu H-L, Ernberg I, Finke J, Rowe M, Klein G, Falk K, Nilsson E, Yadaw M, Busson P, Tursz T and Kallin B. (1988). Int. J. Cancer, 42, 329-338.
12. Fennewald S, van Santen V and Kieff E. (1984). J. Virol., 51, 411-419.
13. Fingeroth JD, Weiss JJ, Tedder TF, Strominger JL, Piro PA and Fearson DT. (1984). Proc. Natl. Acad. USA, 81, 4510-4514.
14. Graham FL and van der Eb AJ. (1973). Virology, 52, 452-457.
15. Hammerschmidt W, Sugden B and Baichwal VR. (1989). J. Virol., 63, 2469-2475.
16. Henle G and Henle W. (1976). Int. J. Cancer, 17, 1-7.
17. Henle G, Henle W and Diehl V. (1968). Proc. Natl. Acad. Sci. USA, 59, 94-101.
18. Hu L-F, Zabarovsky ER, Chen F, Cao S-L, Ernberg I, Klein G and Weinberg G. (1991). J. Gen. Virol., 72, 2399-2409.
19. Huen DS, Henderson SA, Croom-Carter D and Rowe M. (1995). Oncogene, 10, 549-560.
20. Jeng K-C, Hsu C-Y, Liu M-T, Chung T-T and Liu S-T. (1994). J. Clin. Microbiol., 32, 28-31.
21. Kaye KM, Izumi KM, Mosialos G and Kieff E. (1995). J. Virol., 69, 675-683.
22. Kieff E and Liebowitz D. (1990). Virology: Epstein-Barr virus and its replication. Fields BN and Knipe DM (ed). Raven Press: New York. pp. 1889-1920.
23. Knecht H, Bachmann E, Brousset P, Rothenberger S, Einsele H, Lestou VS, Delsol G, Bachmann F, Ambros PF and Odermatt BF. (1995). Oncogene, 10, 523-528.
24. Laemmli UK. (1970). Nature, 227, 680-685.
25. Liebowitz D, Kopan R, Fuchs E, Sample J and Kieff E. (1987). Mol. Cell. Biol., 7, 2299-2308.
26. Lindahl T, Adams A, Bjursell G, Bornkamm GW, Kaschka-Dierich G and Jehn U. (1976). J. Mol. Biol., 102, 511-530.
27. Lupton S and Levine AJ. (1985). Mol. Cell. Biol., 5, 2533-2542.
28. Martin J and Sugden B. (1991). J. Virol., 65, 3246-3258.
29. Miller WE, Edwards RH, Waling DM and Raab-Traub N. (1994). J. Gen. Virol., 75, 2729-2740.
30. Moorthy RK and Thorley-Lawson DA. (1993a). J. Virol., 67, 1638-1646.
31. Moorthy RK and Thorley-Lawson DA. (1993b). J. Virol., 67, 2637-2645.
32. Mosials G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C and Kieff E. (1995). Cell, 80, 389-399.
33. Niederman JC, McCollum RW, Henle G and Henle W. (1968). JAMA, 203, 205-209.
34. Pathmanathan R, Prasad U, Sadler R, Flynn K and Raab-Traub N. (1995). N. Engl. J. Med., 333, 693-698.
35. Purtilo DT, Sakamoto K and Saemundsen AK. (1981). Cancer Res., 41, 4226-4235.
36. Saiki RK, Scharf S, Mitchell SW, Mack DH, Sninsky JJ, Krebs JW, Feorino P, Warfield D and Schochetman G. (1988). Science, 230, 1350-1354.
37. Sandvej K, Peh S-C, Anderson BS and Pallesen G. (1994). Blood, 84, 4053-4060.
38. Sanger F, Nicklen S and Coulson AR. (1977). Proc. Natl. Acad. Sci. USA, 74, 5463-5467.
39. Sixbey JW, Nedrud JG and Raab-Traub N. (1984). N. Engl. J. Med., 310, 1225.
40. Su I-J, Hseih H-C, Lin K-H, Uen W-C, Kao C-L, Chen A-L, Cheng A.L, Kadin ME and Chen J-Y. (1991). Blood, 77, 799-808.
41. Towbin H, Staehelin H and Gordon J. (1979). Proc. Natl. Acad. Sci. USA, 76, 4350-4354.
42. Trivedi P, Hu L-F, Chen F, Christensson B, Masucci MG, Klein G and Weinberg G. (1994). Eur. J. Cancer, 30A, 84-88.
43. Walling DM, Clark NM, Markovitz DM, Frank TS, Braun DK, Eisenberg E, Krutchkoff DJ, Felix DF and Raab-Traub N. (1995). J. Inf. Dis., 171, 1122-1130.
44. Wang D, Liebowitz D and Kieff E. (1985). Cell, 43, 831-840.
45. Wang F, Tsang S-F, Kurilla MG, Cohen JI and Kieff E. (1990). J. Virol., 64, 3407-3416.
46. Yates J, Warren N and Sugden B. (1985). Nature, 313, 812-815.
47. Young LS, Dawson C, Clark D, Rupani H, Busson P, Tursz T, Johnson A and Rickinson A. (1988). J. Gen. Virol., 69, 1051-1065.